Cardiol Therapeutics (CRDL) Non Operating Investment Income (2022 - 2026)
Cardiol Therapeutics (CRDL) reported Non Operating Investment Income of -$1.1 million for Q1 2026, down 212.53% quarter-over-quarter from $991150.5 in Q3 2024.
Cardiol Therapeutics (CRDL) Non Operating Investment Income (2022 - 2026) Analysis & Trends
Cardiol Therapeutics has reported Non Operating Investment Income for 4 years, with the latest figure at -$1.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Cardiol Therapeutics | 162.94 Mn | 142.76 Mn | - | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.12 Mn |
| Mar 31, 2026 | -1.12 Mn |
| Sep 30, 2024 | 991,150.52 |
| Sep 30, 2024 | 991,150.52 |
| Jun 30, 2024 | 505,252.48 |
| Jun 30, 2024 | 505,252.48 |
| Mar 31, 2024 | -1.34 Mn |
| Mar 31, 2024 | -1.34 Mn |
| Sep 30, 2023 | 293,061.91 |
| Sep 30, 2023 | 293,061.91 |
| Jun 30, 2023 | -637,916.11 |
| Jun 30, 2023 | -637,916.11 |
| Mar 31, 2023 | -54,797.45 |
| Mar 31, 2023 | -54,797.45 |
| Sep 30, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 675,787.91 |
| Jun 30, 2022 | 675,787.91 |
| Mar 31, 2022 | -1.68 Mn |
| Mar 31, 2022 | -1.68 Mn |